Auna S.A. (NYSE:AUNA) Receives $6.97 Average Target Price from Brokerages

Auna S.A. (NYSE:AUNA) has received a consensus recommendation of “Hold” from the five analysts that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $6.9667.

A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Wall Street Zen cut Auna from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 5th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th.

Auna Stock Down 0.1%

Shares of Auna stock opened at $5.32 on Monday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.00 and a current ratio of 1.09. Auna has a 52-week low of $4.09 and a 52-week high of $6.85. The company’s 50 day moving average price is $5.05 and its 200-day moving average price is $5.11. The stock has a market capitalization of $393.36 million, a price-to-earnings ratio of 20.44 and a beta of 0.61.

Auna (NYSE:AUNA) last posted its quarterly earnings results on Friday, May 15th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). The firm had revenue of $336.84 million for the quarter, compared to the consensus estimate of $320.54 million. Auna had a net margin of 1.53% and a return on equity of 16.25%. Equities research analysts forecast that Auna will post 0.79 EPS for the current year.

Insider Activity at Auna

In other news, Director John Wilton sold 17,574 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $4.17, for a total transaction of $73,283.58. Following the transaction, the director directly owned 49,974 shares of the company’s stock, valued at approximately $208,391.58. The trade was a 26.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Leon Jesus Zamora bought 6,420 shares of the firm’s stock in a transaction that occurred on Friday, May 29th. The shares were acquired at an average price of $4.15 per share, with a total value of $26,643.00. Following the acquisition, the president owned 69,130 shares of the company’s stock, valued at $286,889.50. This represents a 10.24% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders acquired 83,454 shares of company stock valued at $357,063.

Institutional Trading of Auna

Several large investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC boosted its stake in shares of Auna by 487.7% during the 1st quarter. Renaissance Technologies LLC now owns 668,457 shares of the company’s stock valued at $3,683,000 after purchasing an additional 554,707 shares in the last quarter. Lazard Asset Management LLC bought a new position in Auna in the first quarter worth about $557,000. Arrowstreet Capital Limited Partnership bought a new position in Auna in the first quarter worth about $316,000. Sanctuary Advisors LLC purchased a new stake in Auna in the first quarter worth about $71,000. Finally, Hsbc Holdings PLC purchased a new stake in Auna in the first quarter worth about $324,000.

Auna Company Profile

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.